For early-stage HCC (stages 0 and A), 13 of 21 (61.9%) patients had decreased levels of serum miR-223-3p <0.4, whereas 12 (57.1%) patients had elevated serum AFP at cut-off value of 20 ng/mL. Here, AFP is linked to hepatocellular carcinoma.